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7RESEARCH Open AccessAnti-Müllerian hormone and progesterone levels
produced by granulosa cells are higher when
derived from natural cycle IVF than from
conventional gonadotropin-stimulated IVF
Zahraa Kollmann1*, Nick A Bersinger1,2, Brett D McKinnon2, Sophie Schneider1, Michael D Mueller1
and Michael von Wolff1Abstract
Background: The study was designed to compare the effect of in vitro FSH stimulation on the hormone
production and gene expression profile of granulosa cells (GCs) isolated from single naturally matured follicles
obtained from natural cycle in vitro fertilization (NC-IVF) with granulosa cells obtained from conventional
gonadotropin-stimulated IVF (c-IVF).
Methods: Lutein granulosa cells from the dominant follicle were isolated and cultured in absence or presence of
recombinant FSH. The cultures were run for 48 h and six days. Messenger RNA (mRNA) expressions of anti-Müllerian
hormone (AMH) and FSH receptor were measured by quantitative polymerase chain reaction (qPCR). AMH protein
and progesterone concentration (P4) in cultured supernatant were measured by ELISA and RIA.
Results: Our results showed that the mRNA expression of AMH was significantly higher in GCs from NC- than from
c-IVF on day 6 after treatment with FSH (1 IU/mL). The FSH stimulation increased the concentration of AMH in the
culture supernatant of GCs from NC-IVF compared with cells from c-IVF. In the culture medium, the AMH level was
correlated significantly and positively to progesterone concentration.
Conclusions: Differences in the levels of AMH and progesterone released into the medium by cultured GC as well
as in AMH gene expression were observed between GCs obtained under natural and stimulated IVF protocols. The
results suggest that artificial gonadotropin stimulation may have an effect on the intra-follicular metabolism.
A significant positive correlation between AMH and progesterone may suggest progesterone as a factor influencing
AMH secretion.
Keywords: Human granulosa cells, Natural cycle, Anti-Müllerian hormone, Follicle-stimulating hormone receptor,
Progesterone, IVFBackground
Follicle growth is a complex process involving a function-
ing and bidirectional communication between each oocyte
and its surrounding somatic cell compartments [1-3]. At
the antral stage of follicular growth most follicles undergo
atresia, although due to gonadotropin stimulation, some
will enter the pre-ovulatory stage [4-6]. However, the exact* Correspondence: zahraa.kollmann@insel.ch
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unless otherwise stated.mechanism of follicle selection and primordial follicle acti-
vation is not yet completely understood.
The follicle-stimulating hormone (FSH) and its receptor
(FSHR) play an essential role in recruitment and follicle
growth [7,8]. In humans the dominant follicle selection
may depend on differential FSH sensitivity amongst a
growing cohort of small antral follicles. Various growth fac-
tors related to the TGFβ superfamily contribute to this se-
lection process by interacting with gonadotropin-induced
signals [9-11]. Anti-Müllerian hormone (AMH) is one such
growth factor that is produced by granulosa cells (GCs)ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Study population and ovarian cycle
characteristics
Variables Group A Group B P
NC-IVF cIVF
Patients 21 20 ns
Age, mean +/− SEM (yrs) 35.4 +/− 0.8 37.6 +/− 0.8 ns
Range 28-41 31-42
Etiology of infertility (n/Total)
Male factor
7/21 8/20
Tubal factor 4/21 2/20
Endometriosis 4/21 2/20
Idiopathic 6/21 8/20
AMH (pmol/L) 14.2 +/− 3.7 22.4 +/− 5.1 0.1430
Number of oocytes retrieved 1.0 +/− 0.0 6.9 +/− 1.2 <0.0001***
Follicle Diameter (mm) 18.2 +/− 0.4 18.5 +/− 0.4 ns
Data other than P values are mean +/− SEM.
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maximal levels observed in secondary, preantral and small
antral follicles ≤ 4 mm [7]. AMH may play an important
role in primordial follicle selection and cyclic growing fol-
licle recruitment [12]. Moreover, AMH might regulate the
selection of the dominant follicle through the inhibitory ef-
fects of AMH on the initial recruitment of primary follicles
from the resting primordial follicle pool [13-15] and
through the regulation of FSH, sensitivity in the human
ovary [16].
In addition, recent research has suggested a relationship
exists between follicular fluid AMH concentrations of the
pre-ovulatory follicle and the occurrence of a clinical preg-
nancy. Embryo implantation rates were higher when oo-
cytes were obtained from follicles with high AMH
concentrations in the follicular fluid, but not in the serum
on cycle day 3 and on the day of oocyte pickup [17,18]. Fur-
thermore, it has been shown that follicular AMH concen-
trations were approximately three-fold higher in NC-IVF
follicles than in c-IVF-follicles at the time of ovum pickup
[19]. In addition, previous studies have shown that the im-
plantation potential of oocytes is higher in NC-IVF [20,21]
compared with c-IVF [22], and it can be expected that the
NC-IVF follicles would closely represent physiologically
normal follicles. Thus it can be assumed that the artificial
stimulation of follicle growth that occurs in c-IVF treatment
has certain effects on the follicles. In the context of a pro-
ject studying the difference and clinical consequences be-
tween natural and stimulated IVF treatment cycles with
different approaches, we have decided to set up a series of
in vitro experiments to assess the endocrine function of
GCs derived from both NC-IVF and c-IVF protocols. This
was done by measuring the AMH production and secretion
and the progesterone (P4) secretion by cultured granulosa
cells both with and without FSH stimulation.
Methods
Study population and treatment cycles
The study was approved by the local ethical committee
before commencement (reference no. 12–023, Inselspital
Berne, Teaching and Research Management, IRB In-
ternal Review Board, approved 11 October 2012) and pa-
tients' approval was given by written consent.
GCs were collected at oocyte retrieval from 41 women
(mean age 36.5 +/− 3.8 (SD), range 28–42) and with regu-
lar cycles who had been referred to our clinic for infertility
treatment between October 2012 and August 2013. The
study population was divided into two groups according to
the selected treatment protocol. (A) Patients (n = 21)
undergoing NC-IVF without medical intervention except
for the administration of hCG (Pregnyl; MSD, Switzerland)
36 h before follicle aspiration and (B) patients (n = 20)
undergoing a stimulation cycle (c-IVF) with GnRH antag-
onist (Orgalutran, Ganirelix 0,25 mg, MSD, Switzerland)protocol and using highly purified hMG (Menopur, Meno-
tropin hMG, Ferring Pharmaceuticals, Baar, Switzerland)
for 8–10 days and daily doses of 150–300 IU of hMG,
followed by hCG (Pregnyl). Transvaginal ultrasound
guided oocyte retrieval was performed 36 h later. In c-IVF,
granulosa cells were collected from the first aspirated ma-
tured (MII) large follicle (LF; > = 18 mm). The causes of in-
fertility were mainly male or idiopathic in both groups; the
individual numbers are given in Table 1.
Collection and culture of granulosa cells
Immediately after oocyte retrieval and the isolation of the cu-
mulus oophorus complex, granulosa cells were isolated from
the follicular fluid and flushing medium [23]. Only the lead-
ing follicle was analysed in stimulated cycles without pooling.
The total aspirate volume was collected in a 15-ml polystyr-
ene test tube (BD Falcon) and centrifuged at 440 × g for
10 min. The GCs containing pellets were clearly visible and
were separated, avoiding aggregates with red blood cells as
described elsewhere [24], with the exception of the density
gradient, which had to be omitted due to the small number
of GCs present in single follicles. The Pellets were suspended
in 0.4 mL freezing medium (Iscove’s modified Dulbecco
medium, IMDM, Gibco-Ivitrogen, Paisley, Scotland) without
phenol red and with DMSO (10% v/v) and stored at −80°C
until used in the culture experiment. To ensure that suffi-
cient GC populations had been obtained in the flushing pro-
cedure, a direct smear slide was made from the pellet for
each sample. The smear slides were prepared by cyto-
centrifugation, fixed immediately with Cytostat 400® spray
(Simat AG, Glattbrugg, Switzerland) and stained with
Papanicolau (PAP) reagent [25].
For the culture experiment the isolated GCs were
thawed at 37°C and washed twice in culture medium
(IMDM containing foetal bovine serum (10% v/v), penicillin,
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and without phenol red. Cells were counted with Trypan
blue for evaluation of cell concentration and viability, then
seeded at 10,000 live cells/cm2 into 48-well plates and main-
tained in complete medium with foetal bovine serum and
the antibiotic/antimycotic reagent. After 24 h of incubation
in 1 ml total volume, the supernatants were then aspirated
and medium containing recombinant FSH (Gonal-F®,
0.1 IU/mL or 1.0 IU/mL, Merck Serono S.A., Geneva,
Switzerland) was added. One well from each sample was
cultured as a control in the absence of FSH. The cultures
were run for 48 h and six days. For the measurement of pro-
gesterone and AMH protein concentrations, 0.5 ml of
supernatant was removed from each well after 48 h and the
remaining volume on day 6 at conclusion of the cul-
ture. Supernatants were centrifuged at 1000 × g for
5 min. Progesterone (P4) was quantified using a com-
mercially available radio-immunoassay (“Coat-a-Count”)
from DPC, Los Angeles, USA. The 3-h incubation protocol
at room temperature was used. For P4 determinations the
introduced supernatant volume had to be diluted 1:5 in the
zero standard as a carrier. The intra-assay coefficient of
variance at the relevant P4 concentrations was between 3.6
and 4.9%. AMH was determined manually with commer-
cially available specific microplate Enzyme-Linked Im-
munosorbent Assay (ELISA). The assay for AMH was
obtained from Cusabio (China). The functional sensitivity
of the assay was 0.375 ng/mL, and the intra- and inter-
assay coefficients of variance were reported to be 15% each.
Culture supernatants were diluted 1:2 in 0.9% NaCl prior
to assay and the protocol of the manufacturer was
followed. The hormone concentrations were expressed
after normalisation by dividing their concentration by the
cell number.
Immunofluorescence staining of granulosa cells for FSH
receptor
Granulosa cells were identified by the expression of the
FSH receptor (FSHR). They were plated on cover slips at
10,000 live cells/cm2 into 48-well plates. After six days of
culture, cells were fixed in paraformaldehyde (4% w/v,
Grogg Chemie, Stettlen, Switzerland) for 10 min. and
rinsed five times in PBS containing Tween-20 (0.1% v/v,
PBST). The slides were incubated with the primary anti-
body against FSH receptor (monoclonal mouse anti-
human FSHR, R&D Systems, England, dilution 1:50), 5%
normal goat serum (NGS), 0.5% casein, in PBS for 90 min.
at room temperature After three washes in PBST, the slides
were incubated with the second antibody, chicken anti-
mouse IgG (H + L) labelled with Alexa® Fluor 488 (Invitro-
gen, USA, dilution 1:200) for 1 h at room temperature.
Then, the slides were washed another three times in PBST.
Nuclei were stained with 4’,6-diamidinmo-2-phenylindole
(DAPI, sigma) at a final concentration of 0.5 μg/mL for10 min. and washed three times for 10 min. in PBST before
mounting in UltraCruz™ Mounting Medium sc-24941
(Santa Cruz Biotechnology Inc.). Fluorescence images
were captured under an Axiovert 40 CFL with Axio-
Cam MRm.Determination of gene expression
Samples with a useful quantity of RNA were extracted from
14 single follicles (NC-IVF) out of n = 21. Another 14 sam-
ples were collected from the c-IVF group with a total num-
ber of 20 samples. Extraction of RNA was achieved by using
the Rneasy® Plus Micro Kit (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s protocol. RNA quantity and
purity were determined with a Nanodrop® Spectrophotom-
eter (Wilmington, USA). Reverse transcription (RT) was
performed with the Quantitech Reverse Transcription kit
(Qiagen, Hilden, Germany) with a concentration of 0.15 ng/
μL RNA in 20 μL. A pre-amplification of cDNA was per-
formed using TaqMan® PreAmp Master Mix Kit (AB, Ap-
plied Biosystems, CA, USA) for 14 cycles, as recommended
by the manufacturer. The subsequent cDNA was used for
quantitative PCR (qPCR) in 20 μL reaction volumes using
the TaqMan® Gene Expression assays (Applied Biosystems
Europe, Zug, Switzerland), in an Applied Biosystems 7900
HT Fast Real Time PCR System. The following primers/
probes were used: AMH (NM_000479, Hs01006984); FSHR
(NM_000145, Hs00174865); with GAPDH (NM_002046,
Hs03929097) and ACTB (NM_001101, Hs00242273) as ref-
erence genes.
The relative gene expression was calculated with the
qBASEplus software (Biogazelle, Zwijnaarde, Belgium)
using a method based on the ΔΔCt method that incor-
porates the use of multiple reference genes.Statistical analysis
All statistical analyses were performed using GraphPad
Prism. The non-parametric Mann–Whitney U-test was
performed to compare the expression of mRNA between
the GCs from the cIVF group and cells from NC-IVF. For
analysis of variance, the two-way ANOVA test was used to
compare the effect of IVF method and the effect of FSH
treatment. The Spearman Rank Correlation Analysis was
applied to determine whether there was a significant rela-
tionship between progesterone and AMH concentrations
in the culture medium. The significance level was set at
p < 0.05. All data are expressed as the mean +/− SEM.Results
The clinical parameters in NC-IVF and c-IVF patients
are summarized in Table 1. There were no differences in
patient age, AMH level in serum or follicle diameter be-
tween treatment groups.
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In the PAP staining method nuclei appear as homoge-
neously dark blue chromatin whereas the cytoplasm ap-
pears as a pale eosinophilic coloration (Figure 1A).
Human granulosa cells in culture attached within
24 h, the red blood cells were visible in the initial cul-
ture, but did not remain after gentle shaking and a
change of the media after 24 h of culture. The FSHR in
the GCs were identified using immunostaining on day 6.
Cells cultured and treated with FSH (0.1 IU/ml, 1 IU/
mL) have shown a fibroblast-like morphology and an
intracellular signal for FSHR (Figure 1C, D).Effect of FSH on the expression of follicle stimulating
receptor and of AMH mRNA
NC-IVF GCs stimulated for six days with 1 IU/mL FSH had
a significantly higher AMH mRNA expression compared
with c-IVF GCs (3.41 +/− 1.55, n = 14 vs. 0.053 +/− 0.43,
n = 14; p= 0.0344) (Figure 2A). There was no significant dif-
ference in the expression of FSHR mRNA (4.76 +/− 4.06,
n = 14 vs. 10.34 +/− 5.82, n = 14) in cells obtained from NC
or c-IVF after 1 IU/mL FSH (Figure 2B).Figure 1 Staining for Granulosa cells and Immunofluorescence stainin
Papanicolaou (20x magnification). Bar = 20 μm. Localisation of FSH recepto
Immunofluorescence FSHR staining with monoclonal mouse anti-human F
with DAPI for nuclei. (B) GCs in control culture (without FSH) showing cyto
outgrowth with fibroblast-like morphology; (D) GC culture stimulated with
indicate de novo production (40x magnification). Bar = 40 μm.Effect of FSH on AMH protein levels in the culture media
of GCs
The mean AMH concentration in the conditioned
medium from GCs derived from NC-IVF in the absence
of FSH showed no significant difference from the mean
AMH concentration from the c-IVF GCs after 48 h cul-
ture (12.9 +/− 1.2, n = 21 vs. 5.8 +/− 2.5 ng/10,000 cells,
n = 20). While after 1 IU/mL FSH treatment at 48 h
there was a significant difference between the NC-IVF
and c-IVF GCs (47.4 +/− 4.2, n = 21 vs. 8.7 +/− 3.0 ng/
10,000 cells, n = 20). FSH (1 IU/mL) increased the AMH
concentration in the culture medium of GCs from NC-
IVF significantly (p = 0.0201) when compared with con-
trol group without FSH. Moreover, the level of AMH
was significant higher in treated GCs from NC-IVF with
FSH (1 IU/mL) when compared with treated GCs from
c-IVF (p = 0.0046) (Figure 3A). After six days of culture,
both the unstimulated (control groups) and 1 IU/mL
FSH-stimulated GCs groups did not exhibit a significant
difference between the NC-IVF and the c-IVF, see
(Figure 3B). In the control group from NC-IVF and
c-IVF, the concentration of AMH was (18.1 +/− 2.9,
n = 21 vs. 14.8 +/− 1.8 ng/10,000 cells, n = 20). In theg for FSH receptor. (A) Aggregated granulosa cells stained with
r (FSHR) in human granulosa cells (GC) after six days in culture,
SHR (primary), chicken anti-mouse (Alexa, secondary), counterstained
plasmic vesicles; (C) GC culture stimulated with FSH 0.1 IU/mL showing
FSH 1 IU/mL showing an intracellular signal for FSHR which could
Figure 2 Effect of FSH on the expression of FSHR- and of AMH- mRNA in GCs from NC-IVF and c-IVF. Gene expression of AMH mRNA
(panel A) and FSHR mRNA (panel B) levels by qPCR in the granulosa cell lysate after six days of culture in 28 GC preparations (NC-IVF, N = 14,
open bars; c-IVF, N = 14, closed bars).
Kollmann et al. Reproductive Biology and Endocrinology  (2015) 13:21 Page 5 of 8FSH-stimulated group, the concentration of AMH in
NC-IVF decreased after six days, but it remained slightly
higher than in c-IVF (28.1 +/− 8.0, n = 21 vs. 20.9 +/−
4.0 ng/10,000 cells, n = 20).
Effect of FSH on progesterone concentration in the
culture media of GCs
A higher but non-significant increase in P4 was observed
in the GCs from NC-IVF compared with c-IVF (188.0 +/−
60.1, n = 21 vs. 119.0 +/− 20.7 pmol/10,000 cells, n = 20)
after a 48-h treatment with 1 IU/mL FSH (Figure 4A). On
day 6, P4 showed a similar pattern of increasing, but it was
not significant in the culture medium from NC-IVF GCs
compared with c-IVF GCs in the presence of 1 IU/mL
FSH (201.0 +/− 93.3, n = 21 vs. 101.09 +/− 19.3 pmol/
10,000 cells, n = 20) (Figure 4B). A significant positive cor-
relation after six days of treatment with 1 IU/mL FSH be-
tween Progesterone and AMH concentrations from both
NC-IVF GCs (r = 0.89, p < 0.0001) and from c-IVF GCs
(r = 0.64, p = 0.014) was observed.Figure 3 Effect of FSH on AMH concentrations in the culture media o
the culture medium of granulosa cells (GCs) isolated from conventionally s
cultured in absence (control, open bars) and presence of FSH (1.0 IU/mL, c
(Graph B). Data are presented as the mean +/− SEM.Discussion
The objective of this study was to compare the GCs ob-
tained from c-IVF and NC-IVF by analyzing the produc-
tion of both progesterone and AMH and their subsequent
responsiveness to FSH exposure in vitro. The results indi-
cate that both groups of GCs retain FSHR, the expression
of which can be further induced by FSH treatment. The
NC-IVF GCs, however, produced significantly more AMH
mRNA and secreted significantly more AMH upon FSH
exposure. In addition, a six-day FSH treatment of both
groups resulted in the secretion of more P4 from the NC-
IVF cells compared with the c-IVF cells. The results of this
study therefore suggest that GCs from NC-IVF retain a
higher sensitivity to FSH compared with GCs from c-IVF.
It is therefore possible that c-IVF stimulation may result in
GCs reaching their peak progesterone production capabil-
ities during the stimulatory cycle.
A major finding of this study is the increased AMH
mRNA expression in GCs from NC-IVF after a six-day FSH
(1 IU/mL) treatment. Previous studies on the relationshipf GCs from NC-IVF and c-IVF. Comparison of AMH concentrations in
timulated IVF (c-IVF, N = 20) and from natural cycle IVF (NC-IVF, N = 21),
losed bars). Incubation in culture was 48 h (Graph A) and 6 days
Figure 4 Effect of FSH on progesterone concentration in the culture media of GCs from NC-IVF and c-IVF. Concentration of progesterone
(P4) in the culture medium of granulosa cells (GCs) isolated from conventionally stimulated (c-IVF, N = 20) and from natural cycle IVF (NC-IVF,
N = 21), cultured in absence (control) and presence of FSH (0.1 IU/mL, 1.0 IU/mL). Incubation in culture was 48 h (Graph A) and 6 days (Graph B).
Data are presented as the mean +/− SEM.
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ent. Taieb et al. [26] showed that both FSH and cAMP up-
regulated AMH mRNA expression in human luteinized
GCs, whereas Pellatt et al. [27] did not detect any effect of
FSH on AMH production by GCs derived from normal
ovaries, but in GCs from women with polycystic ovaries
FSH stimulation decreased significantly AMH levels. A fur-
ther study also reported a FSH-stimulated AMH increase in
GCs from both normo-ovulatory and oligo/anovulatory
PCOS women [28]. The observations from this latter group
support our results and suggest that elevated AMH secre-
tion in cultured GCs from NC-IVF would not depend on
the previous production of the hormone in small antral
follicles.
GCs from NC-IVF also showed a significant increase
in in vitro secretion of AMH after 48 h exposure to
1 IU/mL FSH. After six days this increase in AMH se-
cretion from NC-IVF compared with c-IVF was still
present, however the higher variation between the
different culture preparations may have hindered
the analysis of statistical significance. Our results
from both protein (Figure 3) and gene expression
(Figure 2A) for AMH show the same trend as previ-
ously reported for the follicular fluid concentrations of
the same hormone [19] although statistical significance
was not reached in the absence of FSH stimulation in vitro.
The expression of the FSH receptor and the effects of FSH
stimulation vary throughout the different stage of GC dif-
ferentiation [29]. The mechanism of how gonadotropins
affect AMH secretion in GC is not clear, although it is pos-
sible that the follicular and the luteal phases have differing
dynamics [30,31].
Another finding which we consider important was that
after a six-day culture, P4 concentrations were increased in
NC-IVF compared with the c-IVF after 1 IU/mL FSH andthat AMH secretion was correlated with P4 concentrations
in the both groups but especially strongly in the NC-IVF
group. The long incubation time has been initially chosen
in order to reach a higher sensitivity for both the absolute
hormone levels in the supernatant and for the difference in
these levels between the different hormone treatments. A
shorter, potentially more physiologically relevant incuba-
tion period would have been difficult to control for tech-
nical reasons.
P4 is the major steroid synthesized by luteinized
GCs [32], and it is therefore possible that the luteini-
zation of GCs changes the follicular capacity to pro-
duce AMH. Previous evidence shows that the level of
P4 declines during final follicular maturation [33,34],
and the degree of this maturation and luteinization
may influence AMH production by the GCs [30]. It
has also been shown that the serum and follicular
levels of AMH decline immediately after hCG admin-
istration but rise again four days later [30]. Similarly,
it has been reported that in natural IVF cycles an al-
teration in the hormonal milieu after the LH surge in-
creases serum AMH levels on the day of follicle
aspiration, which reflects early pre-ovulatory changes
after hCG administration [31]. Therefore, these results
suggest that c-IVF results in lower concentrations of
AMH secreted from GCs. A number of reasons for
this reduced production and secretion are possible:
First, c-IVF is characterized by the growth of several
follicles following multiple follicle recruitment during
the initial stimulation step compared with NC-IVF. It can
be speculated that the non-physiological recruitment of
multiple follicles results in intrinsic abnormalities in the
ovarian follicles themselves and in relation to the numbers
of recruited and aspirated follicles. This is suggested by
several studies that investigated follicular and serum AMH
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gonadotropins [35-37]. Second, an exogenous gonado-
tropin administration during the follicular phase would
correlate with a decrease of AMH secretion. A study which
compared the changes of serum AMH levels between
spontaneous cycles and FSH treated cycles during the fol-
licular phase did not find a change in AMH plasma levels
in the spontaneous cycles, but did find a change in AMH
plasma levels in the FSH treated cycles [38].
A minor limitation of the current study is the use of hu-
man lutein GCs. This is not the best model to study the
regulation of AMH by gonadotropins because these cells
have been exposed to exogenous hCG administration. Be-
cause of this exposure to hCG administration, in vitro studies
do not perfectly reflect the in vivo situation during follicular
maturation. However, progesterone production is an ac-
cepted marker for GC responsiveness to FSH stimulation.Conclusions
Our study has shown that luteinized granulosa cells ob-
tained on the day of oocyte retrieval after either c-IVF or
NC-IVF react differently to FSH stimulation in vitro.
GCs from NC-IVF retain their physiological capacity to
respond to FSH stimulation by increasing their produc-
tion and secretion of AMH and progesterone. Moreover,
the reduced AMH production of GCs obtained from
c-IVF follicles suggests that for future research, treat-
ment with exogenous gonadotropins might force the
production of oocytes even from non-competent follicles. If
an adaption of the stimulation protocols in c-IVF could im-
prove the intrafollicular metabolism and thereby increases
the oocyte quality, remains to be evaluated.
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